These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7099785)

  • 21. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute infectious mononucleosis and coincidental measles virus infection.
    Atrasheuskaya AV; Kameneva SN; Neverov AA; Ignatyev GM
    J Clin Virol; 2004 Oct; 31(2):160-4. PubMed ID: 15364274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles in patients suspected of having Rocky Mountain spotted fever.
    Nieburg PI; D'Angelo LJ; Herrmann KL
    JAMA; 1980 Aug 22-29; 244(8):808-9. PubMed ID: 6771427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
    Wong-Chew RM; Beeler JA; Audet S; Santos JI
    J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Exanthematous viral diseases and measles: serology].
    Pérez-Chóliz V; Cisterna R; Armas H; Araus R; Gómez Lus R; Bueno M
    An Esp Pediatr; 1984 Jan; 20(1):8-17. PubMed ID: 6703539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of susceptibility to measles in Italy. Serological Study Group.
    Salmaso S; Gabutti G; Rota MC; Giordano C; Penna C; Mandolini D; Crovari P
    Bull World Health Organ; 2000; 78(8):950-5. PubMed ID: 10994277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Measles antibodies concentration in vaccinated children and adolescents with autoimmune hepatitis].
    Szenborn L; Kacprzak-Bergman I; Zaleska I; Gruszka J
    Pol Merkur Lekarski; 2004 Oct; 17(100):326-30. PubMed ID: 15690693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles.
    Polack FP; Hoffman SJ; Crujeiras G; Griffin DE
    Nat Med; 2003 Sep; 9(9):1209-13. PubMed ID: 12925847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of a trial of an erythrocyte measles diagnostic agent in public health institutions].
    Polzik TP; Kashkina GB; Andrianova DP; Bol'shakova SL; Petrova MA
    Tr Inst Im Pastera; 1981; 56():112-4. PubMed ID: 6764964
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental measles. II. Infection and immunity in the rhesus macaque.
    Zhu YD; Heath J; Collins J; Greene T; Antipa L; Rota P; Bellini W; McChesney M
    Virology; 1997 Jun; 233(1):85-92. PubMed ID: 9229928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 38. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment.
    LeBaron CW; Beeler J; Sullivan BJ; Forghani B; Bi D; Beck C; Audet S; Gargiullo P
    Arch Pediatr Adolesc Med; 2007 Mar; 161(3):294-301. PubMed ID: 17339511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical measles in adolescents and young adults.
    Martin DB; Weiner LB; Nieburg PI; Blair DC
    Ann Intern Med; 1979 Jun; 90(6):877-81. PubMed ID: 443683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.